Participate in Clinical Research
Date posted: July 11, 2014
Help Prevent Adverse Reactions to Medications
Study description:
The Canadian Pharmacogenomics Network for Drug Safety (CPNDS) aims to help solve the drug safety problem by developing genetic tests that predict which patients are at risk for a serious adverse drug reaction. This will allow doctors to prescribe drugs based on a patient’s genetic profile: the right drug at the right dose for each child. CPNDS researchers are based in all the major children’s hospitals across Canada. The researchers are collecting patient DNA samples, analyzing genes, and comparing patient reactions to various medications.
Enrolling:
Closed
Who can participate:
We are looking for any child or teenager under 19 years of age, who has experienced a serious side effect or reaction to a medication. If you are interested in participating in this study, please contact us and we will meet with you once during your next routine clinical visit at SickKids. During the meeting we will ask you some questions about your/your child's medication history and take a small saliva sample of you/your child. It will take about 15 minutes of your time.
Principal investigator:
Lewis, Tamorah
Official study title:
1000007907 - Canadian Pharmacogenomic Network for Drug Safety (CPNDS)
Interested in participating in this study?
Contact name:
Smita Karande
Telephone:
(416)8137654 ext205675
Email:
Study posting
| Study title: | Help Prevent Adverse Reactions to Medications |
|---|---|
| Study description: | The Canadian Pharmacogenomics Network for Drug Safety (CPNDS) aims to help solve the drug safety problem by developing genetic tests that predict which patients are at risk for a serious adverse drug reaction. This will allow doctors to prescribe drugs based on a patient’s genetic profile: the right drug at the right dose for each child. CPNDS researchers are based in all the major children’s hospitals across Canada. The researchers are collecting patient DNA samples, analyzing genes, and comparing patient reactions to various medications. |
| Enrolling: |
Closed
|
| Recruitment information: | We are looking for any child or teenager under 19 years of age, who has experienced a serious side effect or reaction to a medication. If you are interested in participating in this study, please contact us and we will meet with you once during your next routine clinical visit at SickKids. During the meeting we will ask you some questions about your/your child's medication history and take a small saliva sample of you/your child. It will take about 15 minutes of your time. |
| Date posted: | 2014-07-11 |
| Principal investigator: | Lewis, Tamorah |
| Official study title: | 1000007907 - Canadian Pharmacogenomic Network for Drug Safety (CPNDS) |
Interested in participating in this study?
| Contact name: | Smita Karande |
|---|---|
| Telephone: | (416)8137654 ext205675 |
| Email: | smita.karande@sickkids.ca |